Research location
Wilrijk
Belgium
Advertisement
Research activity in Wilrijk
BelgiumCureCurrent currently publishes aggregate city-level research activity for this location: 178 trials and 178 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Wilrijk
178 linked trials · page 2 of 4An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical PracticeNCT02552940 · 2015-10-31 · 1 site observation
COMPLETED
PALbociclib CoLlaborative Adjuvant StudyNCT02513394 · 2015-08-01 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)NCT02425891 · 2015-06-23 · 1 site observation
COMPLETED
A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]NCT02367794 · 2015-06-11 · 1 site observation
COMPLETED
Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast CancerNCT02402712 · 2015-05-06 · 1 site observation
COMPLETED
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT02367781 · 2015-04-16 · 1 site observation
COMPLETED
Tecfidera Slow-Titration StudyNCT02428231 · 2015-04-01 · 1 site observation
TERMINATED
Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With FulvestrantNCT02374099 · 2015-03-13 · 1 site observation
TERMINATED
Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast CancerNCT02278120 · 2014-11-20 · 1 site observation
COMPLETED
A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal ReceptorsNCT02162719 · 2014-08-19 · 1 site observation
COMPLETED
Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)NCT02245568 · 2014-08-01 · 1 site observation
TERMINATED
A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerNCT02131064 · 2014-06-25 · 1 site observation
COMPLETED
Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.NCT01972217 · 2014-04-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast CancerNCT02049957 · 2014-02-13 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast CancerNCT01966471 · 2014-01-31 · 1 site observation
COMPLETED
A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT02031458 · 2014-01-22 · 1 site observation
COMPLETED
TOSCARA Study: A Study of Subcutaneous Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis Naïve to RoActemra/Actemra TreatmentNCT02031471 · 2014-01-01 · 1 site observation
COMPLETED
Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast CancerNCT01958021 · 2013-12-17 · 1 site observation
COMPLETED
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)NCT01942135 · 2013-09-26 · 1 site observation
COMPLETED
Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast CancerNCT01857193 · 2013-09-06 · 1 site observation
COMPLETED
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored StudiesNCT01794793 · 2013-06-10 · 1 site observation
COMPLETED
A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]NCT01846416 · 2013-05-30 · 1 site observation
COMPLETED
A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian CancerNCT01815294 · 2013-05-01 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)NCT01772472 · 2013-04-03 · 1 site observation
COMPLETED
A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic SettingNCT01808573 · 2013-03-29 · 1 site observation
COMPLETED
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast CancerNCT01740336 · 2013-02-06 · 1 site observation
COMPLETED
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)NCT01772004 · 2013-01-31 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based TreatmentNCT01702571 · 2012-11-27 · 1 site observation
COMPLETED
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's DiseaseNCT01689233 · 2012-10-01 · 1 site observation
COMPLETED
Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric CancerNCT01602406 · 2012-09-21 · 1 site observation
COMPLETED
Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) PatientsNCT01634061 · 2012-09-01 · 1 site observation
COMPLETED
Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase InhibitorNCT01610284 · 2012-08-07 · 1 site observation
COMPLETED
A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K ActivationNCT01572727 · 2012-08-01 · 1 site observation
COMPLETED
A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in MonotherapyNCT01705730 · 2012-07-31 · 1 site observation
COMPLETED
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsNCT01576666 · 2012-07-01 · 1 site observation
COMPLETED
An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast CancerNCT01677455 · 2012-07-01 · 1 site observation
COMPLETED
Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast CancerNCT01528345 · 2012-04-01 · 1 site observation
TERMINATED
Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple SclerosisNCT01480076 · 2012-02-01 · 1 site observation
COMPLETED
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid TumorsNCT01482156 · 2012-01-01 · 1 site observation
COMPLETED
The BEACON Study (Breast Cancer Outcomes With NKTR-102)NCT01492101 · 2011-12-01 · 1 site observation
COMPLETED
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast CancerNCT01358877 · 2011-11-08 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed TherapyNCT01419197 · 2011-09-01 · 1 site observation
COMPLETED
A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole TherapyNCT01381874 · 2011-08-24 · 1 site observation
COMPLETED
Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)NCT01405820 · 2011-08-01 · 1 site observation
COMPLETED
External ValidatIon Trial of ASTER TrialNCT01332240 · 2011-04-01 · 1 site observation
UNKNOWN
Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast CancerNCT01186991 · 2011-03-01 · 1 site observation
COMPLETED
A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without TrastuzumabNCT01285466 · 2011-01-01 · 1 site observation
COMPLETED
A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE)NCT01219933 · 2011-01-01 · 1 site observation
COMPLETED
Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-betaNCT01252355 · 2011-01-01 · 1 site observation
TERMINATED
A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast CancerNCT01196052 · 2010-10-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.